珠海润都制药股份有限公司
Swati Spentose Pvt. Ltd.
Country: CN CDE+DMF+CEP HIGH
🇨🇳 CDE
44
44 products shown
🇺🇸 DMF
11
11 products shown
🇪🇺 CEP
10
10 products shown
Total
65
registrations
🇨🇳 CDE 注册 (44)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Amlodipine 氨氯地平 | 88150-42-9 | Class I | Y20240001262 |
| Amlodipine 氨氯地平 | 88150-42-9 | Class I | Y20240001261 |
| Azilsartan Medoxomil 阿齐沙坦 | 863031-21-4 | Class A | Y20210000299 |
| Azilsartan Medoxomil Potassium MY008211A | 863031-21-4 | Class A | Y20220000492 |
| Candesartan Cilexetil 坎地沙坦酯 | 139481-59-7 | Class A | Y20170000131 |
| Carboxyamidotriazole 羧胺三唑 | 99519-84-3 | Class I | Y20200001181 |
| Dasatinib 达沙替尼 | 302962-49-8 | Class A | Y20170001371 |
| Dexibuprofen 右旋布洛芬 | 51146-56-6 | Class A | Y20210000195 |
| Dexrazoxane 右雷佐生 | 24584-09-6 | Class A | Y20200000986 |
| Diclofenac 双氯芬酸二乙胺 | 15307-86-5 | Class I | Y20250001115 |
| Diclofenac Sodium 双氯芬酸钠 | 15307-86-5 | Class A | Y20190021545 |
| Duloxetine 盐酸度洛西汀 | 116539-59-4 | Class A | Y20170000807 |
| Esomeprazole Magnesium 埃索美拉唑镁 | 119141-88-7 | Class A | Y20210000622 |
| Glucosamine 盐酸氨基葡萄糖 | 3416-24-8 | Class A | Y20230001261 |
| Higenamine 盐酸去甲乌药碱 | 11041-94-4 | Class I | Y20240000059 |
| Hydrochlorothiazide 氢氯噻嗪 | 58-93-5 | Class A | Y20240000290 |
| Hydroxychloroquine Sulfate 盐酸地尔硫？ | 747-36-4 | Class A | Y20220000403 |
| Irbesartan 厄贝沙坦 | 138402-11-6 | Class A | Y20190009727 |
| Isosorbide Dinitrate 硝酸异山梨酯 | 87-33-2 | Class A | Y20240000478 |
| Isosorbide Mononitrate 单硝酸异山梨酯 | 16051-77-7 | Class A | Y20220000036 |
| Itopride 盐酸伊托必利 | 122898-67-3 | Class A | Y20190009712 |
| Lansoprazole 兰索拉唑 | 103577-45-3 | Class A | Y20190009470 |
| Lanthanum Carbonate 碳酸镧 | 587-26-8 | Class I | Y20240001423 |
| Levobupivacaine 盐酸左布比卡因 | 27262-48-2 | Class A | Y20190004099 |
| Lidocaine 利多卡因 | 137-58-6 | Class A | Y20210000231 |
| Losartan Potassium 氯沙坦钾 | 114798-26-4 | Class I | Y20240001335 |
| Mosapride 枸橼酸莫沙必利 | 112885-41-3 | Class I | Y20240001424 |
| Moxifloxacin 盐酸莫西沙星 | 151096-09-2 | Class A | Y20170000798 |
| Nicergoline 尼麦角林 | 27848-84-6 | Class A | Y20190006587 |
| Ofloxacin 氧氟沙星 | 82419-36-1 | Class A | Y20190002952 |
| Olmesartan Medoxomil 奥美沙坦酯 | 144689-63-4 | Class A | Y20170000394 |
| Piperaquine 磷酸哌喹 | 51709-02-5 | Class A | Y20190006781 |
| Quinidine 硫酸奎尼丁 | 50-54-4 | Class A | Y20170001464 |
| Rabeprazole Sodium 雷贝拉唑钠 | 117976-89-3 | Class A | Y20190009605 |
| Regadenoson 瑞加诺生 | 313348-27-5 | Class A | Y20210000559 |
| Sacubitril/valsartan Sodium 沙库巴曲缬沙坦钠 | 137862-53-4 | Class A | Y20240000743 |
| Sacubitril/valsartan Sodium 沙库巴曲缬沙坦钠 | 137862-53-4 | Class A | Y20200001073 |
| Sodium Pantothenate 泛酸钠 | 79-83-4 | Class A | Y20190009707 |
| Telmisartan 替米沙坦 | 144701-48-4 | Class I | Y20240001072 |
| Telmisartan 替米沙坦 | 144701-48-4 | Class A | Y20209990018 |
| Valaciclovir 盐酸伐昔洛韦 | 124832-26-4 | Class A | Y20190007854 |
| Valsartan 缬沙坦 | 137862-53-4 | Class A | Y20190009810 |
| Vonoprazan 富马酸伏诺拉生 | 881681-00-1 | Class I | Y20250000526 |
| Voriconazole 伏立康唑 | 137234-62-9 | Class A | Y20190004098 |
🇺🇸 DMF 注册 (11)
| Product | CAS | DMF Number | Date |
|---|---|---|---|
| Candesartan Cilexetil Non-sterile Bulk Drug Substance 坎地沙坦酯 | 145040-37-5 | - | 2022-11-04 |
| Hydroxychloroquine Sulfate 盐酸地尔硫？ | 747-36-4 | - | 2022-08-18 |
| Irbesartan 厄贝沙坦 | 138402-11-6 | - | 2008-06-27 |
| Irbesartan, Non-sterile Bulk Drug Substance 厄贝沙坦颗粒 | 138402-11-6 | - | 2019-11-12 |
| Olmesartan Medoxomil 奥美沙坦酯 | 144689-63-4 | - | 2018-02-09 |
| Sacubitril Carboxyl Compound Non-sterile Bulk Drug Substance Intermediate | - | - | 2023-12-29 |
| Sacubitril Sodium 沙库巴曲钠 | 149690-05-1 | - | 2018-12-31 |
| Sacubitril/valsartan 缬沙坦二钠 | 137862-53-4 | - | 2021-04-28 |
| Valsartan 缬沙坦 | 137862-53-4 | - | 2012-03-01 |
| Valsartan Disodium 缬沙坦二钠 | 137862-53-4 | - | 2018-12-30 |
| Voriconazole Non-sterile Bulk Drug Substance 伏立康唑 | 137234-62-9 | - | 2023-01-16 |
🇪🇺 CEP 注册 (10)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Candesartan Cilexetil 坎地沙坦酯 | 139481-59-7 | R1-CEP 2013-314 - Rev 01 | - |
| Candesartan Cilexetil, Process 2 | 145040-37-5 | CEP 2023-096 - Rev 01 | - |
| Hydroxychloroquine Sulfate 盐酸地尔硫？ | 747-36-4 | R0-CEP 2021-317 - Rev 00 | - |
| Irbesartan 厄贝沙坦 | 138402-11-6 | CEP 2017-151 - Rev 05 | - |
| Irbesartan, Process II 厄贝沙坦颗粒 | 138402-11-6 | CEP 2021-347 - Rev 02 | - |
| Losartan Potassium 氯沙坦钾 | 114798-26-4 | CEP 2024-123 - Rev 00 | - |
| Olmesartan Medoxomil 奥美沙坦酯 | 144689-63-4 | R1-CEP 2014-121 - Rev 01 | - |
| Telmisartan 替米沙坦 | 144701-48-4 | R0-CEP 2022-179 - Rev 00 | - |
| Valsartan 缬沙坦 | 137862-53-4 | CEP 2019-106 - Rev 02 | - |
| Voriconazole 伏立康唑 | 137234-62-9 | CEP 2023-030 - Rev 00 | - |
Source: cde_raw | Updated: 2026-04-09 07:23:01